Product Detail

Hydroxyethyl starch series products (hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5) are made from natural waxy corn starch (waxy maize starch) through hydrolysis, hydroxyethylation and refining. Its preparations - hydroxyethyl starch 130 / 0.4 sodium chloride injection and hydroxyethyl starch 200 / 0.5 sodium chloride injection are the best plasma substitutes in the world at present, with good volume expansion effect and little toxic and side effects, which has been widely used in clinic, such as blood or plasma loss and low blood volume caused by operation, burn, sepsis, blood exchange, blood supplement and other purposes.

We, Bojia obtained the registration approval of hydroxyethyl starch 130 / 0.4 API in 2006. After continuously optimizing the process flow, improving the production process, and improving the quality standard, we began to fully implement the European pharmacopoeia standard in 2014, endotoxin limit 1.25eu/g (ep2.5eu / g), batch quantity 1200kg, and annual production capacity over 300 tons . Including meeting domestic customers’ needs of HES, we also export a large number to overseas markets. At present, the sales volume in the international market has exceeded that in the domestic market and hydroxyethyl starch 200 / 0.5 also available too.